Condition
Squamous Cell Carcinoma of the Oropharynx clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Squamous Cell Carcinoma of the Oropharynx clinical trials that are recruiting, at sites in 4 countries (most in United States (2), Germany (2), France (1)). By phase: Phase 2 (2), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 4Countries
Newest Squamous Cell Carcinoma of the Oropharynx clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Platform for studying biomarkers and treatments in head and neck cancer | — | Essen and 1 other locations | Recruiting | Apr 24, 2024 |
| Finding tissue and blood markers that predict response to immunotherapy in recurrent or metastatic upper throat and mouth squamous cell cancer | — | Paris and 2 other locations | Recruiting | Sep 29, 2023 |
| Reducing radiation therapy for head and neck cancer patients | Phase 2/3 | Erlangen, Bavaria | Recruiting | Sep 11, 2023 |
| Lower dose radiation therapy for HPV positive head and neck cancer | Phase 2 | Miami, Florida and 4 other locations | Recruiting | Jul 27, 2023 |
| Observing viral biomarkers and microRNAs in oropharyngeal tumors and occult cancers related to HPV | — | Rome | Recruiting | Jun 26, 2023 |
| Personalized treatment for early-stage p16+ oropharyngeal cancer | Phase 2 | Ann Arbor, Michigan | Recruiting | Jun 8, 2023 |
All recruiting trials (6)
-
Platform for studying biomarkers and treatments in head and neck cancer
This study is trying to gather information on how well different treatments work for people with advanced head and neck cancer to help improve future care.
-
Finding tissue and blood markers that predict response to immunotherapy in recurrent or metastatic upper throat and mouth squamous cell cancer
This project will try to find tumor and blood markers that predict whether adults with recurrent or metastatic squamous cell cancer of the oropharynx or nearby upper aerodigestive sites will respond to PD‑1 immunotherapy.
-
Reducing radiation therapy for head and neck cancer patients
This study is testing if cutting back on radiation for head and neck cancer patients can help reduce side effects while still keeping the cancer under control.
-
Lower dose radiation therapy for HPV positive head and neck cancer
This study is testing if a lower dose of radiation therapy can safely treat HPV positive head and neck cancer while causing fewer side effects.
-
Observing viral biomarkers and microRNAs in oropharyngeal tumors and occult cancers related to HPV
This study is testing if certain viral markers and microRNAs in oropharyngeal tumors can help doctors better diagnose and monitor HPV-related cancers and find new treatments.
-
Personalized treatment for early-stage p16+ oropharyngeal cancer
This study is testing two personalized treatment options for people with early-stage p16+ oropharyngeal cancer to see which one works best and is safer.
Related topics
Quick answers
How many Squamous Cell Carcinoma of the Oropharynx clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (2 trials), Germany (2 trials), France (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.